Ian Mortimer, President & CEO: Xenon Pharmaceuticals XENE Planned sale · Filed 03/10

Trade details

Type: Planned sale notice
Stock: Xenon Pharmaceuticals XENE
Person: Ian MortimerPresident & CEO
Planned sale date: 26/03/10
Filed: 26/03/10

More to sell after $18.1M in 3 months

Xenon Pharmaceuticals trades, last 26 weeks

What else happened in Xenon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/08~04/09

Ian Mortimer's recent trades

Ian MortimerPresident & CEO
BuyXenon Pharmaceuticals
Buy
Xenon Pharmaceuticals
XENE
$1.1M
30,000 sh
$1.1M
Filed 10/01
Traded 09/30
Ian MortimerPresident & CEO
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$403.6K
7,308 sh
$403.6K
Filed 03/13
Traded 03/13
Ian MortimerPresident & CEO
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 plan
Xenon Pharmaceuticals
XENE
$403.6K
7,308 sh
$403.6K
Filed 03/13
Traded 03/13
Ian MortimerPresident & CEO
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$4M
65,000 sh
$4M
Filed 03/11
Traded 03/09
Ian MortimerPresident & CEO
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$3.7M
61,652 sh
$3.7M
Filed 03/11
Traded 03/09

Ian Mortimer, CEO — plans to sell 11,269 sh of Xenon Pharmaceuticals XENE · $677.4K · around 03/10 · 10b5-1 plan | Whalegun